Money hunt
5 minutes ago
I smell green dude!!!
Elevai Biosciences, a Subsidiary of Elevai Labs Inc., Announces FDA Regulatory Pathway for EL-22, a Pioneering Obesity Therapy Targeting Fat Loss and Muscle Preservation
EL-22, a first-in-class myostatin asset, is being developed as a potential combination